Middle East Pharmaceutical Approves Capital Increase at EGM

AVALON PHARMA

AVALON PHARMA

4016.SA

0.00

On May 12, 2026, Middle East Pharmaceutical Industries Co. announced the results of its Extraordinary General Assembly meeting held on May 11, 2026, at 18:30 in Riyadh via online technology. The meeting, which achieved a 69.41% shareholder attendance rate, approved the company's capital increase proposal. Five board members and committee chairmen participated in the meeting to oversee the voting process on the agenda items.

Original announcement:

https://www.saudiexchange.sa/wps/portal/saudiexchange/newsandreports/issuer-news/issuer-announcements/issuer-announcements-details/?anId=95294&anCat=1&cs=4016&locale=ar

Attached PDF document link:

https://www.saudiexchange.sa/Resources/fsPdf/25633_5507_2026-05-11_18-56-38_en.pdf

Note: The original announcement does not explicitly specify a currency unit. Figures above are reproduced as-is. Please refer to the original announcement for details.

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.